BiondVax LOGO.png
BiondVax Congratulates Dirk Görlich on $1.4 million WLA Prize in Life Sciences
15. November 2022 08:33 ET | BiondVax Pharmaceuticals Ltd.
JERUSALEM, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“BiondVax”), a biotechnology company focused on developing, manufacturing, and...